In Brief This Week: Enigma Diagnostics; Spartan Bioscience; BioDiscovery | GenomeWeb

NEW YORK (GenomeWeb News) – Enigma Diagnostics this week said that it has received a Biomedical Catalyst grant from the UK government to support further development of multiplexed PCR assays using the firm's ResonSense probing technology. It didn't disclose the amount of funding it received under the grant. The firm said it plans to use the money to demonstrate ResonSense can detect and differentiate "many more target sequences in a single closed-tube assay than conventional PCR chemistries."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.